Home

Corporate Governance

AGM Summary

SEC Filings

Financial Reports

Stock Information

Press Releases

Event Calendar

Analyst Coverage

E-mail Alerts

Investor Kit

Information Request

Contact IR
Investor Relations

Corporate Profile
Simcere Pharmaceutical Group (NYSE:SCR, Simcere) is a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China. In recent years, Simcere has been focusing its strategy on the development of innovative pharmaceuticals and first-to-market generics, and has introduced an innovative anti-cancer medication Endu, a first-to-market medication Sinofuan, and first-to-market generics such as Bicun and Anxin. Simcere manufactures and sells antibiotics, anti-cancer medica... More >>
Stock Quote
SCR (Common Stock)
ExchangeNYSE (US Dollar)
Price$9.05
Change (%) Stock is Up 0.17 (1.91%)
Volume31,039
Data as of 07/30/10 4:03 p.m. ET
Minimum 20 minute delay
Refresh quote
Featured Documents
2008 Annual Review Adobe PDF
2008 20F Adobe PDF
Recent Press ReleasesMore >>
DateTitle 
07/14/10Simcere Pharmaceutical Group Provides Notice of Annual General MeetingPrinter Friendly Version
06/30/10Simcere Pharmaceutical Group Files Annual Report on Form 20-FPrinter Friendly Version
06/07/10Simcere Pharmaceutical Group to Acquire Additional Stake in Jilin Boda Pharmaceutical Co. LtdPrinter Friendly Version
05/18/10Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 ResultsPrinter Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Simcere Pharmaceutical Group posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
 
 
 
 
Copyright 2000- www.simcere.com/english All rights reserved.
Tel. 86-25-85566666 fax 86-25-85471729
Design by 71nc.com